1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Therapeutic Enzymes Market, By Product Type
5.1 Introduction
5.2 Chitinase
5.3 Asparginase
5.4 Lipase
5.5 Protease
5.6 Nattokinase
5.7 Serratiopeptidase
5.8 Collagenase
5.9 Ligase
5.10 Other Product Types
6 Global Therapeutic Enzymes Market, By Application
6.1 Introduction
6.2 Leukemia
6.3 Stomach Disorders
6.4 Antitumor
6.5 Skin Ulcers
6.6 Gaucher disease
6.7 Fabry disease
6.8 Other Applications
7 Global Therapeutic Enzymes Market, End User
7.1 Introduction
7.2 Drug manufacturers
7.3 Hospitals
7.4 Private clinics
7.5 Research laboratories
8 Global Therapeutic Enzymes Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Sanofi
10.2 BioMarin
10.3 AbbVie
10.4 F. Hoffmann-La Roche Ltd
10.5 Thermo Fisher Scientific Inc.
10.6 Alexion
10.7 DSM
10.8 Novozymes
10.9 Horizon Pharma
10.10 Allergan
10.11 Johnson and Johnson
10.12 Alexion Pharmaceuticals Inc
10.13 Pfizer Inc.
10.14 Vivus, Digestive Care
10.15 Leadiant Biosciences
10.16 Roche Holdings AG
10.17 Codexis Inc.
List of Tables
Table 1 Global Therapeutic Enzymes Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 3 Global Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 4 Global Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 5 Global Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 6 Global Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 7 Global Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 8 Global Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 9 Global Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 10 Global Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 11 Global Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 12 Global Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 13 Global Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 14 Global Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 15 Global Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 16 Global Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 17 Global Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 18 Global Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 19 Global Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 20 Global Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 21 Global Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 22 Global Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 23 Global Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 24 Global Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 25 North America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 26 North America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 27 North America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 28 North America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 29 North America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 30 North America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 31 North America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 32 North America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 33 North America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 34 North America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 35 North America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 36 North America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 37 North America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 38 North America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 39 North America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 40 North America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 41 North America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 42 North America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 43 North America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 44 North America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 45 North America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 46 North America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 47 North America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 48 North America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 49 Europe Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 50 Europe Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 51 Europe Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 52 Europe Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 53 Europe Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 54 Europe Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 55 Europe Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 56 Europe Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 57 Europe Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 58 Europe Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 59 Europe Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 60 Europe Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 61 Europe Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 62 Europe Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 63 Europe Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 64 Europe Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 65 Europe Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 66 Europe Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 67 Europe Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 68 Europe Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 69 Europe Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 70 Europe Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 71 Europe Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 72 Europe Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 73 Asia Pacific Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 74 Asia Pacific Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 75 Asia Pacific Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 76 Asia Pacific Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 77 Asia Pacific Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 78 Asia Pacific Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 79 Asia Pacific Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 80 Asia Pacific Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 81 Asia Pacific Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 82 Asia Pacific Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 83 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 84 Asia Pacific Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 85 Asia Pacific Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 86 Asia Pacific Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 87 Asia Pacific Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 88 Asia Pacific Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 89 Asia Pacific Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 90 Asia Pacific Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 91 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 92 Asia Pacific Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 93 Asia Pacific Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 94 Asia Pacific Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 95 Asia Pacific Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 96 Asia Pacific Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 97 South America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 98 South America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 99 South America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 100 South America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 101 South America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 102 South America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 103 South America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 104 South America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 105 South America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 106 South America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 107 South America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 108 South America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 109 South America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 110 South America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 111 South America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 112 South America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 113 South America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 114 South America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 115 South America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 116 South America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 117 South America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 118 South America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 119 South America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 120 South America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 121 Middle East & Africa Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 122 Middle East & Africa Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 123 Middle East & Africa Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 124 Middle East & Africa Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 125 Middle East & Africa Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 126 Middle East & Africa Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 127 Middle East & Africa Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 128 Middle East & Africa Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 129 Middle East & Africa Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 130 Middle East & Africa Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 131 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 132 Middle East & Africa Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 133 Middle East & Africa Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 134 Middle East & Africa Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 135 Middle East & Africa Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 136 Middle East & Africa Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 137 Middle East & Africa Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 138 Middle East & Africa Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 139 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 140 Middle East & Africa Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 141 Middle East & Africa Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 142 Middle East & Africa Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 143 Middle East & Africa Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 144 Middle East & Africa Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
| ※参考情報 治療用酵素とは、生体内でさまざまな生化学反応を触媒することによって、病気の治療や管理に用いられる酵素のことです。これらの酵素は、疾患のメカニズムに関与する特定の反応を調整する能力を持っており、医療分野での応用が期待されています。 治療用酵素の種類には、主に代謝異常を改善するために使用される酵素、腫瘍の治療に役立つ酵素、感染症の治療に用いられる酵素などがあります。特に、遺伝性疾患に関連する酵素補充療法は広く知られており、体内で必要な酵素が不足している場合に補充することで機能を改善します。例えば、ファブリー病やポンペ病など、特定の代謝異常によって体内で酵素が欠乏することが原因の病気に対し、外部から酵素を投与することで症状を軽減します。 腫瘍に関しては、特定の酵素が腫瘍細胞の成長を抑える働きを持つことがわかっています。これにより、抗がん剤の効果を高めるために酵素を併用することが研究されています。また、自己免疫疾患の治療においても、酵素が免疫系のバランスを調整する役割を果たすことがあり、これが新たな治療法の開発につながる可能性があります。 感染症においては、酵素が病原体の成長を抑えるメカニズムが注目されています。一部の酵素は、特定の細菌やウイルスを標的にすることで、それらの感染を防ぎ、治療の手助けとなることが期待されています。例えば、抗菌性酵素は、病原性細菌による感染症の予防や治療に使用されることがあります。 治療用酵素の開発に関連する技術には、遺伝子工学や合成生物学、ナノテクノロジーなどが含まれます。これらの技術は、酵素の効率を向上させたり、副作用を減少させたりするために利用されます。特に、遺伝子工学を用いて酵素の構造を改変し、より特異的で効率的な治療ができる酵素を設計することが可能です。また、ナノテクノロジーを活用することで、酵素を体内に targeted delivery する方法も研究が進められています。 治療用酵素の利用は、その効果と安全性に関する研究が進行中であり、今後の発展が期待される分野です。医療現場では、これらの酵素が実際に使用されることで、患者の生活の質を向上させることが期待されています。環境による影響や個体差を考慮した個別化医療の観点からも、治療用酵素は重要な役割を果たすことになるでしょう。 しかし、治療用酵素の使用に関しては留意すべき点もあります。患者に与える副作用や、使用する際の適切な dosages を確立することが重要です。加えて、長期的な効果やリスクについての追跡調査も欠かせません。これにより、治療用酵素が持つポテンシャルを最大限に引き出し、安全に利用できる環境が整えられることが求められます。 今後、治療用酵素の研究が進むにつれて、新たな治療法が開発されることで、さまざまな疾患に対する解決策が提供されることを期待しています。治療用酵素の可能性は広がっており、その影響は医療業界だけでなく、患者の生活に対しても大きな変化をもたらすことができると信じています。治療用酵素の有効性とその安全性が確立されることで、個々の患者に合った治療法の一環として重要な位置を占めることになるでしょう。 |
